Gestational trophoblastic neoplasia staging: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 28: Line 28:
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
All other metastatic sites
All other metastatic sites
|}
{| {{table}}
| align="center" style="background:#f0f0f0;"|'''Modified WHO Prognostic Scoring System as Adapted by FIGO'''
|-
| Scores||0||1||2||4
|-
| Age||<40||≥40||–||–
|-
| Antecedent pregnancy||mole||abortion||term||–
|-
| Interval months from index pregnancy||<4||4–6||7–12||>12
|-
| Pretreatment serum hCG (iu/1)||<103||103–104||104–105||>105
|-
| Largest tumor size (including uterus)||<3||3–4 cm||≥5 cm||–
|-
| Site of metastases||lung||spleen, kidney||gastrointestinal||liver, brain
|-
| Number of metastases||–||1–4||5–8||>8
|-
| Previous failed chemotherapy||–||–||single drug||≥2 drugs"
|}
|}

Revision as of 15:10, 6 October 2015


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]

Stage FIGO Anatomical Staging

I

Disease confined to the uterus

II

GTN extends outside of the uterus, but is limited to the genital structures (adnexa, vagina, broad ligament)

III

GTN extends to the lungs, with or without known genital tract involvement

IV

All other metastatic sites


Modified WHO Prognostic Scoring System as Adapted by FIGO
Scores 0 1 2 4
Age <40 ≥40
Antecedent pregnancy mole abortion term
Interval months from index pregnancy <4 4–6 7–12 >12
Pretreatment serum hCG (iu/1) <103 103–104 104–105 >105
Largest tumor size (including uterus) <3 3–4 cm ≥5 cm
Site of metastases lung spleen, kidney gastrointestinal liver, brain
Number of metastases 1–4 5–8 >8
Previous failed chemotherapy single drug ≥2 drugs"